Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation.
about
Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overviewTissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screeningFunctional cardiac tissue engineeringGeneration of Functional Cardiomyocytes from Efficiently Generated Human iPSCs and a Novel Method of Measuring ContractilityInduced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissuesIdentification and purification of human induced pluripotent stem cell-derived atrial-like cardiomyocytes based on sarcolipin expressionCombinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes."The state of the heart": Recent advances in engineering human cardiac tissue from pluripotent stem cellsSignaling Pathways and Gene Regulatory Networks in Cardiomyocyte DifferentiationMaturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues2D and 3D self-assembling nanofiber hydrogels for cardiomyocyte culture.Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytesMachine learning plus optical flow: a simple and sensitive method to detect cardioactive drugsStromal Cells in Dense Collagen Promote Cardiomyocyte and Microvascular Patterning in Engineered Human Heart Tissue.Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell TherapyNaturally Engineered Maturation of CardiomyocytesProduction of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming.Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors.Present state and future perspectives of using pluripotent stem cells in toxicology researchCardiac muscle regeneration: lessons from development.Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes.iPSC technology--Powerful hand for disease modeling and therapeutic screenHuman pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair.Molecular and functional evidence of HCN4 and caveolin-3 interaction during cardiomyocyte differentiation from human embryonic stem cells.High throughput physiological screening of iPSC-derived cardiomyocytes for drug development.Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.Cardiac differentiation of human pluripotent stem cellsHuman pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives.Computational cardiology and risk stratification for sudden cardiac death: one of the grand challenges for cardiology in the 21st century.Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells.Two dimensional electrophysiological characterization of human pluripotent stem cell-derived cardiomyocyte system.Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a review.Embryonic template-based generation and purification of pluripotent stem cell-derived cardiomyocytes for heart repair.Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractilityConcise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes.Engineering the human pluripotent stem cell microenvironment to direct cell fate.Induced pluripotent stem cells as cardiac arrhythmic in vitro models and the impact for drug discovery.Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes.Heart regeneration with engineered myocardial tissuePluripotent stem cells as a platform for cardiac arrhythmia drug screening
P2860
Q24618089-B357A7D1-8803-446C-AEFA-C0F941F499E2Q26799470-EDB55094-C941-4B78-9F1E-235BA35A8B29Q27024431-D1F0C1C7-E08F-4256-BD3C-836FA5F019AEQ27301480-B39CE882-383D-4F78-8B8B-18297923017AQ27315974-2E9F0473-A8B7-48E9-A02C-282302684D3CQ27320909-4C60EE9E-B405-4CAD-9E66-4E4E1BB6BBE3Q27329596-1C0EB081-36A2-42C6-A8A5-56F4B50855E4Q28084360-FD4F7177-358F-4440-B54C-89628C4940B1Q28087290-9B4C56DC-52CA-432A-AB34-C4CF1D45342AQ28550738-8BD1507B-8CF8-4AD6-9B16-9C856EA2D0D6Q30537357-8ACF1B53-5307-4775-98E0-A2B3597D716BQ30574106-37153FB4-104D-475D-B3AD-B79C76386828Q30656460-818ECDB9-EC9C-4C42-8CAF-13C497B992BEQ30746389-8500A105-BB0C-48CB-B12F-6993F7ED9171Q31056955-393F6595-3EF6-48EE-91AD-BD72DA6A2729Q33639096-87DA9AFC-BBE2-4906-88B6-C8E7CC653664Q34245487-5BF36523-BECD-44E4-8F80-8DA9DF1343D6Q34289899-DEC3CB2D-0EED-4289-BC1C-7143E227D82DQ34520935-D168BA03-9855-4976-9CC8-1F0A6A4AD2D7Q34588417-E821593C-B531-4757-B29B-2F6373BE136EQ35414785-6B815734-A93E-4C07-929C-035B3544D97AQ36082427-A582FA6C-A68B-49D3-8B79-8DACD081EC48Q36279078-D7C7C214-7C2B-4820-8757-10CF143B4D09Q36853145-0D9E54F1-70DC-4B97-BD82-8D6170F7F46BQ36948480-60DDA20D-D9BA-4911-93E9-8DE728FFFCD8Q37120932-809CD1AE-1D56-4E8C-B9A7-7B634F5F9648Q37294215-BD90C003-573F-455D-919E-997D00F212F1Q37372183-75D8CDF7-CEFF-4112-AB75-85F106F35AB6Q37466831-089C0C00-C51A-4213-A04C-69ED9D4C3AD3Q37542604-6254E9F2-06D5-4205-83BE-CEF8CD792626Q37683821-43D749CB-B3D8-4E61-8EB0-97D972E37CD6Q37844011-02B54DAB-23A5-40C6-806B-B615489B8A03Q38027106-30D2B301-0EAC-4512-80D5-8875A8750021Q38042792-5ACED9EE-D80A-4079-907D-2545CEA66C10Q38077159-04CE8960-7EBD-4371-AE62-1185F1160369Q38091202-50095D3C-E627-4772-ADDB-415C61BE7BD2Q38167806-C07E8A96-0945-4CB4-BC25-F2FC3A027D3CQ38182186-40E7E19A-AFB6-4317-A3EC-F0EB3DEDA801Q38211168-BE801E29-47DF-486C-9E5F-D75DC8538D72Q38235190-85E6996B-95C0-4ED6-91C6-FBB394A8FF0D
P2860
Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Non-cardiomyocytes influence t ...... ocytes during differentiation.
@en
Non-cardiomyocytes influence t ...... ocytes during differentiation.
@nl
type
label
Non-cardiomyocytes influence t ...... ocytes during differentiation.
@en
Non-cardiomyocytes influence t ...... ocytes during differentiation.
@nl
prefLabel
Non-cardiomyocytes influence t ...... ocytes during differentiation.
@en
Non-cardiomyocytes influence t ...... ocytes during differentiation.
@nl
P2093
P2860
P356
P1476
Non-cardiomyocytes influence t ...... ocytes during differentiation.
@en
P2093
Brandon Nelson
Changsung Kim
Huei-Sheng Vincent Chen
Karen A Wei
Maria Talantova
Mark Mercola
Maryam Majdi
Sean Spiering
P2860
P304
P356
10.1089/SCD.2009.0349
P577
2010-06-01T00:00:00Z